CME webinar: 988 Suicide and Crisis Lifeline (recorded)
Nov. 2022Education/Webinars
"What the webinar will cover*
Pennsylvania and its approach to 988 will:
Presenters:
Watch now
Watch the recording of the 988 Suicide and Crisis Lifeline webinar
Provider is responsible for verifying CME eligibility.
*This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity."
Pennsylvania and its approach to 988 will:
- Provide medical professionals with information and data related to suicide
- Offer background on the National Suicide Prevention Lifeline, a national toll-free resource for anyone to call during a mental health crisis, including its new 988 phone number that gives Pennsylvanians access to 24/7 crisis support.
- Educate providers on the lifeline’s support, prevention, and crisis resources.
- Highlight the importance of educating patients, families and communities about the lifeline.
Presenters:
- Matthew B. Wintersteen, PhD, Associate Professor, Director of Research, Thomas Jefferson University/Jefferson Medical College, Department of Psychiatry & Human Behavior
- Alin Severance, MD, Medical Director, Behavioral Health Services, UPMC Health Plan; Associate Medical Director, Community Care Behavioral Health Organization
Watch now
Watch the recording of the 988 Suicide and Crisis Lifeline webinar
Provider is responsible for verifying CME eligibility.
*This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity."
Recent Announcements
October 2025 UPMC for You and UPMC Community HealthChoices formulary update
Effective Oct. 1, 2025, Xifaxan and Retin-A (cream, gel) will no longer be covered by UPMC for You and UPMC Community HealthChoices due to nonparticipation in the Medicaid Drug Rebate Program.Oct. 2025Pharmacy Updates
Voluntary nationwide recall: Ocaliva (Intercept – September)
Intercept Pharmaceuticals, Inc. is voluntarily withdrawing Ocaliva® (obeticholic acid) from the market. Ocaliva is used to treat a rare liver disease called primary biliary cholangitis (PBC).Oct. 2025Pharmacy Updates
HelpScript service helps patients enroll in manufacturer copay assistance programs
End-to-end provider support helps ensure a smooth submission processOct. 2025Important Notices